Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program
(NASDAQ: INTS) Delayed: 4.10 +0.10 (2.50%)
Previous Close $4.00    52 Week High $ 
Open $3.99    52 Week Low $ 
Day High $4.11    P/E N/A 
Day Low $3.99    EPS $ 
Volume 4,494